Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform.
Adult
Betacoronavirus
/ isolation & purification
COVID-19
Clinical Trials as Topic
Coronavirus Infections
/ complications
Counseling
Female
Humans
Internet
Male
Pandemics
Pneumonia, Viral
/ complications
SARS-CoV-2
Smoking Cessation
Smoking Cessation Agents
/ therapeutic use
Substance-Related Disorders
Telephone
Treatment Outcome
Varenicline
/ therapeutic use
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
02
06
2020
revised:
16
07
2020
accepted:
25
07
2020
entrez:
20
8
2020
pubmed:
20
8
2020
medline:
18
9
2020
Statut:
ppublish
Résumé
Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and monitoring via telephone calls and/or video chat sessions. Our experiences suggest that this pandemic will lead to changes for both future clinical trial participants and project staff. While challenges remain, it will be important to assessing the impact of these changes with regard to participant experiences and treatment outcomes.
Identifiants
pubmed: 32811627
pii: S0740-5472(20)30356-1
doi: 10.1016/j.jsat.2020.108100
pmc: PMC7403863
pii:
doi:
Substances chimiques
Smoking Cessation Agents
0
Varenicline
W6HS99O8ZO
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108100Subventions
Organisme : NCI NIH HHS
ID : R01 CA206193
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016056
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Am J Addict. 2014 May-Jun;23(3):197-204
pubmed: 24724875
Curr Addict Rep. 2019 Jun;6(2):86-97
pubmed: 32010548
Nicotine Tob Res. 2020 Apr 28;:
pubmed: 32343816